JUNS

Jupiter Neurosciences, Inc. is a clinical-stage biotechnology company headquartered in Jupiter, Florida, specializing in the development of innovative pharmaceutical therapies targeting neuroinflammation-related disorders through its proprietary resveratrol platform. The company is focused on advancing its robust drug development pipeline, aimed at providing breakthrough treatments for various neurological conditions amid a growing demand for effective neurotherapeutics. With a strong commitment to research and development, Jupiter Neurosciences is well-positioned to make significant contributions to the pharmaceutical landscape and enhance patient outcomes in neurology.